Feasibility and Efficacy of Gastric Underwater Endoscopic Mucosal Resection
- PMID: 38473010
- PMCID: PMC10931230
- DOI: 10.3390/diagnostics14050536
Feasibility and Efficacy of Gastric Underwater Endoscopic Mucosal Resection
Abstract
Gastric cancer, a leading cause of cancer-related deaths globally, necessitates effective and early detection and treatment strategies. Endoscopic resection techniques, particularly endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD), have evolved significantly, enhancing the treatment of gastric neoplasms. Underwater endoscopic mucosal resection (UEMR) is a widely used technique for the resection of duodenal and colorectal neoplasms. However, the feasibility and efficacy of UEMR in the stomach are not well established. This retrospective observational study, conducted at a tertiary medical center, evaluated the efficacy and safety of UEMR in 81 patients with gastric neoplasms. Thus, it indicates that UEMR is a highly effective and safe technique for managing small to medium-sized gastric neoplasms, achieving 100% en bloc and 93.8% R0 resection rates with a low incidence of complications. Moreover, the procedure time was found to be significantly shorter for UEMR compared to ESD, thus highlighting its efficiency. While UEMR demonstrates high safety and efficacy, it is not suitable for all patients, with some requiring conversion to ESD as a treatment option. Despite the promising results, broader validation through extensive and randomized trials is recommended to establish UEMR as a standard approach in gastric cancer management.
Keywords: endoscopic mucosal resection; endoscopy; stomach neoplasms; water.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Morgan E., Arnold M., Camargo M.C., Gini A., Kunzmann A.T., Matsuda T., Meheus F., Verhoeven R.H.A., Vignat J., Laversanne M., et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020–2040: A population-based modelling study. EClinicalMedicine. 2022;47:101404. doi: 10.1016/j.eclinm.2022.101404. - DOI - PMC - PubMed
-
- Pimentel-Nunes P., Libânio D., Marcos-Pinto R., Areia M., Leja M., Esposito G., Garrido M., Kikuste I., Megraud F., Matysiak-Budnik T., et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51:365–388. doi: 10.1055/a-0859-1883. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
